gusperimus has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inagaki, J; Kimura, I; Majima, H; Masaoka, T; Niitani, H; Oguro, M; Ohno, R; Sanpi, K; Suzuoki, Y; Tamura, K | 1 |
| Sterbenz, KG; Tepper, MA | 1 |
1 trial(s) available for gusperimus and Multiple Myeloma
| Article | Year |
|---|---|
Phase I study of NKT-01.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Female; Guanidines; Hemoglobins; Humans; Leukemia; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Platelet Count; Regression Analysis | 1995 |
1 other study(ies) available for gusperimus and Multiple Myeloma
| Article | Year |
|---|---|
Effect of 15-deoxyspergualin on antibody secretion by specific isotypes producing B-cell hybridomas and myelomas.
Topics: Animals; Antibody Formation; B-Lymphocytes; Cell Line; Guanidines; Hybridomas; Immunoglobulin Isotypes; Immunosuppressive Agents; Kinetics; Mice; Multiple Myeloma; Time Factors; Tumor Cells, Cultured | 1994 |